Strengthening and Opening Up Health Research by Sharing Our Raw Data

被引：23

作者：

Gotzsche, Peter C. ^{[1
]}

机构：

[1] Rigshosp, Nord Cochrane Ctr, Dept 3343, DK-2100 Copenhagen O, Denmark

来源：

CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES | 2012年 / 5卷 / 02期

关键词：

ethics;

D O I：

10.1161/CIRCOUTCOMES.112.965277

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：236 / 237

页数：2

共 10 条

[1]

[Anonymous], 2010, COCHRANE DATABASE SY

[2] FLU DRUGS Search for evidence goes on [J].

Cohen, Deborah .

BMJ-BRITISH MEDICAL JOURNAL, 2012, 344 :e458

[3] Complications: tracking down the data on oseltamivir [J].

Cohen, Deborah .

BMJ-BRITISH MEDICAL JOURNAL, 2009, 339

[4] Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias [J].

Dwan, Kerry ;

Altman, Douglas G. ;

Arnaiz, Juan A. ;

Bloom, Jill ;

Chan, An-Wen ;

Cronin, Eugenia ;

Decullier, Evelyne ;

Easterbrook, Philippa J. ;

Von Elm, Erik ;

Gamble, Carrol ;

Ghersi, Davina ;

Ioannidis, John P. A. ;

Simes, John ;

Williamson, Paula R. .

PLOS ONE, 2008, 3 (08)

[5] Why we need easy access to all data from all clinical trials and how to accomplish it [J].

Gotzsche, Peter C. .

TRIALS, 2011, 12

[6] Opening up data at the European Medicines Agency [J].

Gotzsche, Peter C. ;

Jorgensen, Anders W. .

BMJ-BRITISH MEDICAL JOURNAL, 2011, 342

[7]

Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008965.pub4, 10.1002/14651858.CD008965.pub3]

[8] Ensuring safe and effective drugs: who can do what it takes? [J].

Jefferson, Tom ;

Doshi, Peter ;

Thompson, Matthew ;

Heneghan, Carl .

BMJ-BRITISH MEDICAL JOURNAL, 2011, 342 :148-151

[9] FDA is incapable of protecting US "against another Vioxx" [J].

Lenzer, J .

BRITISH MEDICAL JOURNAL, 2004, 329 (7477) :1253-1253

[10] Failing the public health - Rofecoxib, Merck, and the FDA [J].

Topol, EJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (17) :1707-1709

← 1 →